Liang, Zhaoduan <br/><br/>
High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells.  [electronic resource] 

 -  Cancer letters  04 2019 
 - 164-173 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2019.01.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>B7-H1 Antigen--genetics<br/>Cancer Vaccines--immunology<br/>Cell Line<br/>Cell Line, Tumor<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Lymphocyte Activation--immunology<br/>Melanoma--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Programmed Cell Death 1 Receptor--genetics<br/>T-Lymphocytes--immunology